Scoopfeeds — Intelligent news, curated.
AbbVie’s $11 Billion Immunology Bet
business

AbbVie’s $11 Billion Immunology Bet

Forbes · Jun 24, 2026, 4:30 PM

In this week’s edition of InnovationRx, we look at AbbVie’s new megadeal, an agentic AI startup saving Medicare $2 million a week, how new student loan rules could degrade healthcare and more.

Read full story on Forbes → More top stories
Aggregated and edited by the Scoop newsroom. We surface news from Forbes alongside other reporting so you can compare coverage in one place. Editorial policy · Corrections · About Scoop